2015 Half-year report on Innate Pharma’s liquidity contract with Gilbert Dupont
Number of shares and voting rights of Innate Pharma as at June 16, 2015
Number of shares and voting rights of Innate Pharma as at May 18, 2015
Financial update for the first quarter of 2015
Outcome of Annual General Meeting of April 27, 2015
Innate Pharma and AstraZeneca announce global co-development and commercialisation agreement for IPH2201 in immuno-oncology
Innate Pharma and Sanofi collaborate on next generation antibody-drug conjugates using Innate’s site-specific conjugation technology
DSMB recommends continuation of effiKIR trial with two arms
Innate Pharma to hold its Annual General Meeting of Shareholders on April 27, 2015 and the release of its reference document (in french)
Number of shares and voting rights of Innate Pharma as at March 19, 2015
